Behavioral Healthcare

Mislabeled Packaging Results in Recalled ADHD Medication

February 1, 2024 - On January 24, 2024, Azurity Pharmaceuticals sent an announcement to the United States FDA recalling Zenzedi, a brand name for 30 mg dextroamphetamine sulfate tablets, for mislabeled packaging. The recall applies to the F230169A lot, which was shipped between August 23, 2023, and November 29, 2023, with an expiration date of July 2025. The...

Read More


More Articles

Managing Pediatric Behavioral Health with Pharmacological Treatments

by Veronica Salib

Pediatric mental and behavioral health is a large field of research that can be challenging to tackle. Although these conditions are already difficult to manage in adults, pediatric care requires even more consideration when approaching...

ADHD Medication Shortages Prompt Response from the FDA and DEA

by Veronica Salib

On August 1, 2023, the United States Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA) released a public statement updating Americans on the ongoing shortages of prescription...

Vagus Nerve Stimulation Augments Behaviors in Epilepsy Patients

by Veronica Salib

Scientific Reports recently published a study that concluded transcutaneous vagus nerve stimulation (tVNS) altered cooperative behaviors in epilepsy patients. According to the Epilepsy Foundation,...

Recent Articles